Literature DB >> 23196319

Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.

Daniela Poli1, Caterina Cenci, Emilia Antonucci, Elisa Grifoni, Chiara Arcangeli, Domenico Prisco, Rosanna Abbate, Massimo Miniati.   

Abstract

The stratification of recurrence risk after a first episode of venous thromboembolism (VTE) is an important topic of research, especially in patients with pulmonary embolism (PE). Elevated D-dimer levels and residual vein obstruction (RVO) at compression ultrasonography have been studied as predictors of recurrence after withdrawing oral anticoagulant treatment (OAT). It is still unknown if residual perfusion defects (PD) on lung scintigraphy are related to recurrent PE. In the present study, we evaluated the association of PD with PE recurrence. The relationship between PD, elevated D-dimer levels, and RVO was also investigated. We prospectively followed 236 consecutive patients who survived a first episode of objectively confirmed PE, with or without deep-vein thrombosis. After at least three months of OAT, treatment was withdrawn in 139 patients. D-dimer levels were evaluated at one month of OAT withdrawal, RVO was measured, and perfusion lung scan (P-scan) was performed to evaluate PD. During follow-up, 20 patients experienced a recurrent episode of VTE. Elevated D-dimer levels were significantly associated with VTE recurrence, (p=0.003). RVO was present in 22% of the patients with recurrence and in 7.5% of those without (p=0.07). No significant association was found between PD >10% and VTE recurrence, D-dimer, or RVO. In conclusion, we confirmed the positive predictive value of elevated D-dimer levels for recurrent VTE. Residual PD on lung scintigraphy are neither predictive of recurrence nor related to D-dimer levels or RVO.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196319     DOI: 10.1160/TH12-07-0534

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism.

Authors:  Ming Sheng Lim; Dee Nandurkar; Ian Jong; Anita Cummins; Huyen Tran; Sanjeev Chunilal
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

2.  Factors determining altered perfusion after acute pulmonary embolism assessed by quantified single-photon emission computed tomography-perfusion scan.

Authors:  Marc Meysman; Hendrik Everaert; Walter Vincken
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

Review 3.  Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities.

Authors:  Hannah Stevens; Karlheinz Peter; Huyen Tran; James McFadyen
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

4.  Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data.

Authors:  Philippe Robin; Maggie Eddy; Lindsey Sikora; Pierre-Yves Le Roux; Marc Carrier; Francis Couturaud; Benjamin Planquette; Raffaele Pesavento; Marc Rodger; Pierre-Yves Salaun; Grégoire Le Gal
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

5.  Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?

Authors:  Otto Moodley; Hadi Goubran
Journal:  Thromb J       Date:  2015-10-05

6.  Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.

Authors:  Kim A Ma; Susan R Kahn; Arash Akaberi; Carole Dennie; Christopher Rush; John T Granton; David Anderson; Philip S Wells; Marc A Rodger; Susan Solymoss; Michael J Kovacs; Lawrence Rudski; Avi Shimony; Paul Hernandez; Shawn D Aaron; Elena Pena; Gad Abikhzer; Andrew M Hirsch
Journal:  Res Pract Thromb Haemost       Date:  2018-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.